Drug Type Recombinant protein |
Synonyms RS-B.1.351 |
Target |
Action modulators |
Mechanism SARS-CoV-2 S protein modulators(SARS-CoV-2 S protein modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Clinical | United States | 11 Jun 2021 |